Wei Yi,Wu Shengde,Wang Yangcai,Lin Tao,He Dawei,Li Xulian,Liu Junhong,Liu Xing,Hua Yi,Lu Peng,Zhang Deying,Wen Sheng,Wei Guanghui.Antibiotic prophylaxis for febrile urinary tract infections in children with primary vesicoureteral reflux: a meta-analysis[J].J Amry Med Univ (J Third Mil Med Univ),2016,38(13):1552-1558.
Wei Yi,Wu Shengde,Wang Yangcai,Lin Tao,He Dawei,Li Xulian,Liu Junhong,Liu Xing,Hua Yi,Lu Peng,Zhang Deying,Wen Sheng,Wei Guanghui.Antibiotic prophylaxis for febrile urinary tract infections in children with primary vesicoureteral reflux: a meta-analysis[J].J Amry Med Univ (J Third Mil Med Univ),2016,38(13):1552-1558.DOI:
Antibiotic prophylaxis for febrile urinary tract infections in children with primary vesicoureteral reflux: a meta-analysis
Objective To assess the effectiveness and safety of continuous antibiotic prophylaxis (CAP) in the prevention of urinary tract infection (UTI) for the children with vesicoureteral reflux (VUR) by meta analysis. Methods Computer retrieval was carried out in Cochrane library
PubMed
EMBASE
Ovid
Springer
China National Knowledge Infrastructure (CNKI)
VIP database
WanFang Data
and China Biology Medicine disc (CBM) from establishment until May 2015 for randomized controlled trials (RCT) about UTI prevention by comparing CAP and no agent/placebo. The quality of the literature was assessed with Jadad scale according to Cochrane Handbook for systematic reviews of interventions. Meta-analysis was performed to the extracted data by statistical software Rev Man 5.1. The main indicator of observation was the incidence of recurrent urinary tract infections
and the secondary indicator was the new incidence of renal scars. Results There were 8 RCTs incorporated in this study
including 828 cases of antibiotic treatment group and 811 cases of control group. The meta-analyses showed ① The risk of febrile UTI was reduced in the CAP group of (RR=0.69
95%CI: 0.56~0.86
P0.05); ② CAP reduced the occurrence of febrile UTI in the children with VUR of gradeⅠ~Ⅱ (RR=0.57
95%CI: 0.37~0.87
P0.05) and those of grade Ⅲ~Ⅳ (RR=0.76
95%CI: 0.59~0.96
P0.05); ③ Based on the 5 RCTs studying the occurrence of new renal scars in children with VUR
antibiotic treatment had no effect of the risk of new renal scars when compared with those receiving no agent/placebo (RR=1
95%CI: 0.61~1.64
P0.05). Conclusion Regardless of the grade of VUR
CAP exerts significant effect on the prevention of UTI
but has no effect on the occurrence of new renal scars in the children.
Safe and effective concentration of ropivacaine in interscalene brachial plexus block for children aged 6 to 10 years: a sequential allocation study
Electrophysiological characteristics and gene analysis of children with congenital stationary night blindness without fundus abnormalities
Study on age-related normal intracranial pressure and cerebral perfusion pressure thresholds in children
Intervention of unhealthy mood and sleep quality in children with mild COVID-19 in makeshift hospital based on the response mode
Influencing factors of extracorporeal membrane oxygenation on outcomes in critically ill children
Related Author
LI Shangyingying
YANG Li
YANG Fei
TIAN Yaqiong
LIU Ling
GAO Wen
SHI Yuan
TU Shengfen
Related Institution
Department of Anesthesiology Children’s Hospital of Chongqing Medical University, National Clinical Research Center for Child Health and Disorders, Ministry of Education Key Laboratory of Child Development and Disorders, Chongqing Key Laboratory of Child Neurodevelopment and Cognitive Disorders
Department of Ophthalmology, First Affiliated Hospital/Southwest Hospital, Army Medical University (Third Military Medical University)